Citizens Upgrades LeonaBio to Market Outperform, Announces $18 Price Target

LeonaBio, Inc.

LeonaBio, Inc.

LONA

0.00

Citizens analyst Jason N. Butler upgrades LeonaBio (NASDAQ: LONA) from Market Perform to Market Outperform and announces $18 price target.